OM:XVIVOMedical Equipment
Xvivo Perfusion Q4 Margin Compression Tests Bullish Growth Narrative
Xvivo Perfusion's Latest Results Set Against Shifting Profitability
Xvivo Perfusion (OM:XVIVO) has just opened Q1 2026 reporting with recent quarterly figures that include Q4 2025 revenue of SEK 226.1 million and basic EPS of SEK 1.00, against a backdrop of trailing twelve month basic EPS of SEK 0.80 and total revenue of SEK 812.2 million. Over the past few quarters, the company has seen quarterly revenue move between SEK 178.3 million and SEK 227.6 million, while basic EPS has ranged from a...